Trusted advisor to emerging and established medical technology companies poised for growthContact Us
The boundaries of the medical technology world are increasingly blurring with other healthcare subsectors as traditional single-use devices and capital equipment are often incorporating sensor technology, digital solutions, mobile and home use, drug delivery and/or complementary service models.
Our medical technology team works with both emerging and established medical technology companies to be their trusted advisor and partner in mergers and acquisitions, capital raising and strategic collaborations.
Our leading team of professionals leverage their knowledge, experience and singular healthcare focus to help our clients define and achieve their strategic, capital markets and investment objectives.
Related Banking Team
Senior Managing Director, Medical Technology
Jed Cohen is a Senior Managing Director in Investment Banking at SVB Securities covering the Medical Technology sector.
Jed has over 28 years of healthcare investment banking experience, including 12 years at Citigroup and three years at UBS prior to joining SVB Securities in 2009. His transaction experience includes advisory work and financing assignments with clients across the healthcare industry, with an exclusive focus on the medical technology sector since 2000. He disproportionately spends his time with “breakthrough” medical technology companies that are either creating new markets or disrupting existing markets through innovative solutions.
He received a B.S. in Economics from the University of Pennsylvania’s Wharton School.
Senior Managing Director, Medical Technology
Michael Giaquinto is a Senior Managing Director in Investment Banking at SVB Securities covering the Medical Technology sector.
Michael has nearly three decades of healthcare investment banking experience, including 20 years of transactions focused on Medical Technology. Prior to joining the firm in 2018, he served as the Head of Medical Devices & Diagnostics at Greenhill where he spent 10 years dedicated exclusively to providing mergers & acquisitions advisory services to his clients. Prior to Greenhill, Michael spent more than a decade at Citigroup where he served as Co-Head of its U.S. Healthcare Group. Michael also worked in the health care groups of UBS and Kidder, Peabody. He has worked on more than 150 financings and M&A transactions valued at over $100 billion during his career.
He earned his M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University and a B.S. in Accounting from Boston College.
Related Management Team
Global Co-Head of Investment Banking and Global Co-Head of Healthcare Investment Banking
Barry Blake is the Global Co-Head of Investment Banking, and Global Co-Head of Healthcare Investment Banking at SVB Securities. In this role, he co-leads the firm’s healthcare investment banking strategy and initiatives, with a focus on Healthcare Services & Technology. With 25 years of experience, he has built extensive relationships and has proven expertise in healthcare services, medical devices and tools/diagnostics, leveraged finance, and with financial sponsors. Leading the Healthcare Services team at SVB Securities, he has advised on numerous transactions, including the sale of LHC Group to Optum Health, a UnitedHealth Group Company, for $6B.
Barry joined the firm in 2021 from Guggenheim Securities where he was a Senior Managing Director focused on advising healthcare services companies. While at Guggenheim he advised on many transactions including, but not limited to, the $10B sale of Envision to KKR; the $4B sale of Kindred Healthcare to a consortium comprised of TPG, Welsh Carson and Humana; the $2.4B sale of American Medical Response to KKR and the $1B sale of Almost Family to LHC Group. Prior to this, he was the Head of Global Healthcare Mergers and Acquisitions for Citigroup. While at Citigroup he worked on many transactions including, but not limited to, the $34B acquisition of Medco by Express Scripts. He also worked in the M&A and Healthcare groups at Morgan Stanley, JP Morgan and Lehman Brothers. While at JP Morgan he advised on many transactions including, but not limited to, the $4.8B acquisition of NextRx from Wellpoint by Express Scripts.
Barry earned his Bachelor of Arts in Economics from Hendrix College, and his Masters of Business Administration with high distinction from the Amos Tuck School at Dartmouth College.
He has served as a member of the Board of Trustees for each of The Hopkins School in New Haven, CT and Hendrix College in Conway, AR.
Director, Business Manager
Christian Clark is a Director and Business Manager of Investment Banking at SVB Securities. Mr. Clark is responsible for managing the group’s overall operations including strategic planning, financial and business reporting and analytics, people management and recruiting. He supports Healthcare Services & Technology and MD&D investment banking teams.
Mr. Clark joined the firm in 2018 as the Business Manager for Equity Research. He was responsible for managing the Equity Research side of client strategy and for leading many key strategic initiatives in product, process and business development. He was promoted to Associate Director of Equity Research during his time in Equity Research.
Prior to SVB Securities, Mr. Clark worked at Credit Suisse and held a variety of business and strategy positions within the Equities division. Prior to this role, he was a Fixed Income client consultant at Bloomberg LP.
Mr. Clark earned his B.S. in Finance (Summa Cum Laude) from Pennsylvania State University.